Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy

Biomaterials

Volumn 31, Issue 18, 2010, Pages 4909-4917

  Raines, Andrew L ^a   Olivares Navarrete, Rene ^a   Wieland, Marco ^b   Cochran, David L ^c   Schwartz, Zvi ^a,c   Boyan, Barbara D ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b NanoPowers SA   (Switzerland)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Angiogenesis; Microstructure; Osteoblast; Surface energy; Titanium; VEGF

Indexed keywords

ANGIOGENESIS; ANGIOGENIC GROWTH FACTORS; ANGIOPOIETINS; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTORS; HIGH SURFACE ENERGY; IMPLANTED MATERIALS; INTEGRINS; MG63 CELLS; MICRO ARCHITECTURES; MICRO TOPOGRAPHY; NEOVASCULARIZATION; OSSEOINTEGRATION; OSTEOBLAST DIFFERENTIATION; PERI-IMPLANT BONES; PRIMARY HUMAN OSTEOBLASTS; RAPID DIFFERENTIATION; SURFACE ENERGIES; SURFACE ENERGY; SURFACE MICROTOPOGRAPHY; TITANIUM SURFACES; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOACTIVITY; CELL CULTURE; ENDOTHELIAL CELLS; GROWTH KINETICS; INTERFACIAL ENERGY; MICROSTRUCTURE; OCEAN CURRENTS; PEPTIDES; SELF ASSEMBLY; SIGNALING; SURFACE CHEMISTRY; SURFACE TENSION; SURFACES; TITANIUM;

OSTEOBLASTS;

ALKALINE PHOSPHATASE; ALPHA2 INTEGRIN; ANGIOPOIETIN 1; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; OSTEOCALCIN; TITANIUM; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY; VERY LATE ACTIVATION ANTIGEN 2;

ANGIOGENESIS; ARTICLE; BONE REGENERATION; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENERGY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTEGRIN ALPHA CHAINS; INTEGRINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; OSSEOINTEGRATION; OSTEOBLASTS; SURFACE PROPERTIES; TITANIUM;

EID: 77951977686     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.071     Document Type: Article

References (45)

1. Hench L.L., Polak J.M. Third-generation biomedical materials. Science 2002, 295:1014-1017.
2. Jell G., Stevens M.M. Gene activation by bioactive glasses. J Mater Sci Mater Med 2006, 17:997-1002.
3. Kriparamanan R., Aswath P., Zhou A., Tang L., Nguyen K.T. Nanotopography: cellular responses to nanostructured materials. J Nanosci Nanotechnol 2006, 6:1905-1919.
4. Goto T., Yoshinari M., Kobayashi S., Tanaka T. The initial attachment and subsequent behavior of osteoblastic cells and oral epithelial cells on titanium. Biomed Mater Eng 2004, 14:537-544.
5. Boyan B.D., Schwartz Z., Lohmann C.H., Sylvia V.L., Cochran D.L., Dean D.D., et al. Pretreatment of bone with osteoclasts affects phenotypic expression of osteoblast-like cells. J Orthop Res 2003, 21:638-647.
6. Zhao G., Schwartz Z., Wieland M., Rupp F., Geis-Gerstorfer J., Cochran D.L., et al. High surface energy enhances cell response to titanium substrate microstructure. J Biomed Mater Res A 2005, 74:49-58.
7. Buser D., Schenk R.K., Steinemann S., Fiorellini J.P., Fox C.H., Stich H. Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res 1991, 25:889-902.
8. Gotfredsen K., Wennerberg A., Johansson C., Skovgaard L.T., Hjorting-Hansen E. Anchorage of TiO2-blasted, HA-coated, and machined implants: an experimental study with rabbits. J Biomed Mater Res 1995, 29:1223-1231.
9. Cochran D.L., Schenk R.K., Lussi A., Higginbottom F.L., Buser D. Bone response to unloaded and loaded titanium implants with a sandblasted and acid-etched surface: a histometric study in the canine mandible. J Biomed Mater Res 1998, 40:1-11.
10. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
11. Gronowicz G., McCarthy M.B. Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 1996, 14:878-887.
12. Raz P., Lohmann C.H., Turner J., Wang L., Poythress N., Blanchard C., et al. 1alpha,25(OH)2D3 regulation of integrin expression is substrate dependent. J Biomed Mater Res A 2004, 71:217-225.
13. Olivares-Navarrete R., Raz P., Zhao G., Chen J., Wieland M., Cochran D.L., et al. Integrin alpha2beta1 plays a critical role in osteoblast response to micron-scale surface structure and surface energy of titanium substrates. Proc Natl Acad Sci U S A 2008, 105:15767-15772.
14. Wang L., Zhao G., Olivares-Navarrete R., Bell B.F., Wieland M., Cochran D.L., et al. Integrin beta1 silencing in osteoblasts alters substrate-dependent responses to 1,25-dihydroxy vitamin D3. Biomaterials 2006, 27:3716-3725.
15. Duvall C.L., Taylor W.R., Weiss D., Wojtowicz A.M., Guldberg R.E. Impaired angiogenesis, early callus formation, and late stage remodeling in fracture healing of osteopontin-deficient mice. J Bone Miner Res 2007, 22:286-297.
16. Geris L., Gerisch A., Sloten J.V., Weiner R., Oosterwyck H.V. Angiogenesis in bone fracture healing: a bioregulatory model. J Theor Biol 2008, 251:137-158.
17. Abshagen K., Schrodi I., Gerber T., Vollmar B. In vivo analysis of biocompatibility and vascularization of the synthetic bone grafting substitute NanoBone(R). J Biomed Mater Res A 2008.
18. Connolly D.T., Heuvelman D.M., Nelson R., Olander J.V., Eppley B.L., Delfino J.J., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989, 84:1470-1478.
19. Schweigerer L., Neufeld G., Friedman J., Abraham J.A., Fiddes J.C., Gospodarowicz D. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 1987, 325:257-259.
20. Mehta V.B., Besner G.E. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factor 2007, 25:253-263.
21. Koblizek T.I., Weiss C., Yancopoulos G.D., Deutsch U., Risau W. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998, 8:529-532.
22. Deckers M.M., Karperien M., van der Bent C., Yamashita T., Papapoulos S.E., Lowik C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000, 141:1667-1674.
23. Clarkin C.E., Emery R.J., Pitsillides A.A., Wheeler-Jones C.P. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J Cell Physiol 2008, 214:537-544.
24. Carlevaro M.F., Cermelli S., Cancedda R., Descalzi Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 2000, 113:59-69.
25. Collins P.D., Connolly D.T., Williams T.J. Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo. Br J Pharmacol 1993, 109:195-199.
26. Stoelcker B., Echtenacher B., Weich H.A., Sztajer H., Hicklin D.J., Mannel D.N. VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence. J Interferon Cytokine Res 2000, 20:511-517.
27. Baffour R., Berman J., Garb J.L., Rhee S.W., Kaufman J., Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992, 16:181-191.
28. Wakui S. Epidermal growth factor receptor at endothelial cell and pericyte interdigitation in human granulation tissue. Microvasc Res 1992, 44:255-262.
29. Ravindranath N., Wion D., Brachet P., Djakiew D. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate. J Androl 2001, 22:432-443.
30. Cai J., Kehoe O., Smith G.M., Hykin P., Boulton M.E. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophthalmol Vis Sci 2008, 49:2163-2171.
31. Wang D.S., Miura M., Demura H., Sato K. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 1997, 138:2953-2962.
32. Hurley M.M., Abreu C., Gronowicz G., Kawaguchi H., Lorenzo J. Expression and regulation of basic fibroblast growth factor mRNA levels in mouse osteoblastic MC3T3-E1 cells. J Biol Chem 1994, 269:9392-9396.
33. St-Arnaud R. The direct role of vitamin D on bone homeostasis. Arch Biochem Biophys 2008, 473:225-230.
34. McMillan J., Kinney R.C., Ranly D.M., Fatehi-Sedeh S., Schwartz Z., Boyan B.D. Osteoinductivity of demineralized bone matrix in immunocompromised mice and rats is decreased by ovariectomy and restored by estrogen replacement. Bone 2007, 40:111-121.
35. Cole B.J., Bostrom M.P., Pritchard T.L., Sumner D.R., Tomin E., Lane J.M., et al. Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat. Clin Orthop Relat Res 1997, 219-228.
36. Schwartz Z., Raz P., Zhao G., Barak Y., Tauber M., Yao H., et al. Effect of micrometer-scale roughness of the surface of Ti6Al4V pedicle screws in vitro and in vivo. J Bone Joint Surg Am 2008, 90:2485-2498.
37. Mayer H., Bertram H., Lindenmaier W., Korff T., Weber H., Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 2005, 95:827-839.
38. Rupp F., Scheideler L., Olshanska N., de Wild M., Wieland M., Geis-Gerstorfer J. Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J Biomed Mater Res A 2006, 76:323-334.
39. Martin J.Y., Schwartz Z., Hummert T.W., Schraub D.M., Simpson J., Lankford J., et al. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 1995, 29:389-401.
40. Rausch-fan X., Qu Z., Wieland M., Matejka M., Schedle A. Differentiation and cytokine synthesis of human alveolar osteoblasts compared to osteoblast-like cells (MG63) in response to titanium surfaces. Dent Mater 2008, 24:102-110.
41. Siddappa R., Licht R., van Blitterswijk C., de Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 2007, 25:1029-1041.
42. Katopodi T., Tew S.R., Clegg P.D., Hardingham T.E. The influence of donor and hypoxic conditions on the assembly of cartilage matrix by osteoarthritic human articular chondrocytes on Hyalograft matrices. Biomaterials 2009, 30:535-540.
43. Owen T.A., Aronow M.S., Barone L.M., Bettencourt B., Stein G.S., Lian J.B. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 1991, 128:1496-1504.
44. Boyan B.D., Lossdorfer S., Wang L., Zhao G., Lohmann C.H., Cochran D.L., et al. Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. Eur Cell Mater 2003, 6:22-27.
45. Siebers M.C., ter Brugge P.J., Walboomers X.F., Jansen J.A. Integrins as linker proteins between osteoblasts and bone replacing materials. A critical review. Biomaterials 2005, 26:137-146.